The key results have previously been reported as posters at scientific conferences ... Pomerantz Law Firm Investigates Claims On Behalf of Investors of Novavax, Inc. - NVAX Pomerantz LLP is ...

Subscribers to Chart of the Week received this commentary on Sunday, October 27. Indulge, for a second, one last 2024 ...

Novavax, Inc. (Nasdaq: NVAX), a global company advancing protein-based vaccines with its Matrix-M™ adjuvant, today announced that the U.S. Food and Drug Administration (FDA) has removed the ...

A clinical trial has found that Novavax’ COVID-19 vaccine is 86% protective against the UK variant of SARS-CoV-2, only slightly lower than the 96% efficacy seen with the original strain of the ...

Inovio Pharmaceuticals Inc.-3.56% $138.65M ...

A trial participant developed amytrophic lateral sclerosis (ALS), an event deemed unrelated to vaccination. Novavax’s shares jumped in pre-market trading on the news but settled once markets opened.

Eliminating fake vaccine news with pharmacist, nurse, and physician review.